Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Dietz, Julia; Susser, Simone; Vermehren, Johannes; Peiffer, Kai-Henrik; Grammatikos, Georgios; Berger, Annemarie; Ferenci, Peter; Buti, Maria; Müllhaupt, Beat; Hunyady, Bela; Hinrichsen, Holger; Mauss, Stefan; Petersen, Jörg; Buggisch, Peter; Felten, Gisela; Hüppe, Dietrich; Knecht, Gaby; Lutz, Thomas; Schott, Eckart; Berg, Christoph; Spengler, Ulrich; von Hahn, Thomas; Berg, Thomas; Zeuzem, Stefan; Sarrazin, Christoph; European HCV Resistance Study Group (2018). Patterns of Resistance-associated Substitutions in Patients With Chronic HCV Infection Following Treatment with Direct-acting Antivirals. Gastroenterology, 154(4):976-988.e4.

Zeuzem, Stefan; Soriano, Vicente; Asselah, Tarik; Gane, Edward J; Bronowicki, Jean-Pierre; Angus, Peter; Lohse, Ansgar W; Stickel, Felix; Müllhaupt, Beat; Roberts, Stuart; Schuchmann, Marcus; Manns, Michael; Bourlière, Marc; Buti, Maria; Stern, Jerry O; Gallivan, John-Paul; Voss, Florian; Sabo, John P; Böcher, Wulf; Mensa, Federico J (2015). Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis. Antimicrobial Agents and Chemotherapy, 59(2):1282-1291.

Asselah, Tarik; Zeuzem, Stefan; Soriano, Vicente; Bronowicki, Jean-Pierre; Lohse, Ansgar W; Müllhaupt, Beat; Schuchmann, Marcus; Bourlière, Marc; Buti, Maria; Roberts, Stuart K; Gane, Edward J; Stern, Jerry O; Voss, Florian; Baum, Patrick; Gallivan, John-Paul; Böcher, Wulf O; Mensa, Federico J (2015). ITPA genotypes predict anemia but do not affect virological response with interferon-free faldaprevir, deleobuvir, and ribavirin for hcv infection. PLoS ONE, 10(12):e0144004.

Zeuzem, Stefan; Asselah, Tarik; Angus, Peter; Zarski, Jean-Pierre; Larrey, Dominique; Müllhaupt, Beat; Gane, Ed; Schuchmann, Marcus; Lohse, Ansgar W; Pol, Stanislas; Bronowicki, Jean-Pierre; Roberts, Stuart; Arasteh, Keikawus; Zoulim, Fabien; Heim, Markus; Stern, Jerry O; Nehmiz, Gerhard; Kukolj, George; Böcher, Wulf O; Mensa, Federico J (2013). Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results. Antiviral Therapy, 18(8):1015-1019.

Zeuzem, Stefan; Soriano, Vincent; Asselah, Tarik; Bronowicki, Jean-Pierre; Lohse, Ansgar W; Müllhaupt, Beat; Schuchmann, Marcus; Bourlière, Marc; Buti, Maria; Roberts, Stuart K; Gane, Ed J; Stern, Jerry O; Vinisko, Richard; Kukolj, George; Gallivan, John-Paul; Böcher, Wulf-Otto; Mensa, Federico J (2013). Faldaprevir and deleobuvir for HCV genotype 1 infection. New England Journal of Medicine, 369(7):630-639.

This list was generated on Tue Sep 18 19:22:01 2018 CEST.